Information  X 
Enter a valid email address

Port Erin Biopharma (PEBI)

  Print      Mail a friend

Monday 18 June, 2012

Port Erin Biopharma

Director/PDMR Shareholding

RNS Number : 5331F
Port Erin Biopharma Investments Ltd
18 June 2012
 



Port Erin Biopharma Investments Limited

 

 ("Port Erin" or the "Company")

 

Director's Dealing

 

 

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.

 

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.

 

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.

 

 

Enquiries:

 



 

Port Erin Biopharma Investments Limited

 

Denham Eke

(+44) 1624 639396

 

 

Libertas Capital Corporate Finance Limited

 

Sandy Jamieson

(+44) 20 7569 9650

 

 

Rivington Street Corporate Finance Limited

 

John Levinson

(+44) 20 7562 3350

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKDLBFLQFLBBV